Quality Matters | U.S. Pharmacopeia Blog

// June 09, 2022

Pharmaceutical continuous manufacturing: What drug makers need to know...

Pharmaceutical continuous manufacturing (PCM) technology has gained increased attention from industry and policymakers as one way to help expand domestic manufacturing of essential medicines

Ron Piervincenzi, Ph.D.

Supply Chain

// March 14, 2022

The medicines supply chain: Increasing visibility to strengthen preparedness ...

We are doing our part by improving visibility into the upstream medicines supply chain so that vulnerabilities can be predicted and addressed before potential disruptions occur. Our solution to aid early detection of risk factors that can lead to drug shortages is USP’s Medicine Supply Map.

Vimala Raghavendran

Global Health

// March 07, 2022

Bolstering capabilities to support the supply of quality medicines...

Strengthening the medicine supply chain is a global imperative and one to which USP has long been committed. Our efforts to help strengthen the medicine supply chain aligns directly with our mission to advance the supply of quality-assured medicines to improve the health and wellbeing of people around the world.

Emily Kaine, M.D.

Supply Chain

// June 09, 2022

Pharmaceutical continuous manufacturing: What drug makers need to know...

Pharmaceutical continuous manufacturing (PCM) technology has gained increased attention from industry and policymakers as one way to help expand domestic manufacturing of essential medicines

Ron Piervincenzi, Ph.D.

Healthcare

// March 08, 2022

mRNA Vaccines: Your Questions Answered

Thanks to the vaccines developed to fight the pandemic, mRNA, specifically mRNA vaccines, has become a topic of public interest. Non-scientists want to understand what mRNA vaccines are, how they work and whether they should trust them.

USP Staff

Supply Chain

// February 24, 2022

Advanced manufacturing technology: Reducing barriers to adoption...

We need to reduce the barriers to adoption of advanced manufacturing technology (AMT) like pharmaceutical continuous manufacturing (PCM).

Joseph Hill

Featured Videos

View All Videos

Quality Medicines for Malaria

Global Health

// May 24, 2018

Quality Medicines for Malaria

Marie Lamy with Asia Pacific Leaders Malaria Alliance discusses how one country is tackling drug resistance in order to eradicate Malaria.

Rob Anderson

Poor quality medicines and drug resistance

Global Health

// May 24, 2018

Poor quality medicines and drug resistance

Harvard professor and physician Ashish Jha describes how poor quality medicines create the perfect opportunity for superbugs.

Rob Anderson

Quality medicines and sub-Saharan Africa

Global Health

// May 24, 2018

Quality medicines and sub-Saharan Africa

Global health advocate Mirfin Moundu talks about the dangers of poor quality medicines and how they are a threat to many Africans in treating infectious diseases and non-communicable diseases.

Rob Anderson

Discover More:

I am interested in:

and:

Supply Chain

// October 13, 2021

Standards Enable a Strong Medicines Supply Chain

Standards play an important role in the global medicines supply chain, helping governments and manufacturers increase the availability of safe, quality medicines, as well as building patient and health provider trust. In fact, quality standards are a big reason why we in the U.S. can get a prescription filled at our neighborhood pharmacy and trust that the medicine we receive will be safe and work as it should.

Rob Anderson

Best Practices in State-Level Procurement in India During the COVID-19 Pandemic: Adapting Lessons from a USP Study in Kerala

Medicines

// September 09, 2021

Best Practices in State-Level Procurement in India During the COVID-19 Pandemic: Adap...

In the global race to procure vaccines, India—the world’s leading supplier of generic medicines—faces an acute shortage of COVID-19 vaccines. Often dubbed the world’s pharmacy, India must now obtain enough vaccines for its own people. The federal government is in charge of procuring COVID-19 vaccines. However, significant challenges in quality assurance—including storage, distribution, and getting shots into arms at the last mile—remain at the state level.

Kishor Mogulluru

Medicines

// August 18, 2021

USP Expands Global COVID-19 Response to Tackle Substandard & Falsified Vaccines...

The challenges posed by COVID-19 transcend international borders and require global solutions. This includes addressing the potential for substandard and falsified (SSF) COVID-19 vaccines, particularly in low- and middle-income countries. At the U.S.

Jaap Venema

Fostering Broader Access to Quality -assured COVID-19 Vaccines from Development to Distribution

Medicines

// May 17, 2021

Fostering Broader Access to Quality-assured COVID-19 Vaccines from Development to Dis...

Those stakeholders involved in the development and distribution of vaccines – including developers, manufacturers, distributors, and healthcare practitioners – must all work together to maintain the quality of authorized and approved COVID-19 vaccines.

Anthony Lakavage, J.D.

Medicines

// May 05, 2021

Manufacturing COVID-19 vaccines in Africa

While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.

Perrer Tosso, Ph.D.

Medicines

// April 21, 2021

USP Volunteer Profile: Developing the COVID-19 Vaccine Handling Toolkit...

USP’s success in its mission to improve global public health through creation of standards and related programs depends in large part on the work of volunteers.